These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2315268)

  • 1. Pharmacokinetics of recombinant human erythropoietin in chronic haemodialysis patients.
    Nielsen OJ
    Pharmacol Toxicol; 1990 Feb; 66(2):83-6. PubMed ID: 2315268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of recombinant human erythropoietin in dialysis patients after single and multiple subcutaneous administrations.
    Kampf D; Eckardt KU; Fischer HC; Schmalisch C; Ehmer B; Schostak M
    Nephron; 1992; 61(4):393-8. PubMed ID: 1501734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of recombinant human erythropoietin after subcutaneous injection at different sites.
    Jensen JD; Jensen LW; Madsen JK
    Eur J Clin Pharmacol; 1994; 46(4):333-7. PubMed ID: 7957518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
    Lancet; 1989 Feb; 1(8635):425-7. PubMed ID: 2563798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of epoetin (recombinant human erythropoietin) after long term therapy in patients undergoing haemodialysis and haemofiltration.
    Gladziwa U; Klotz U; Bäumer K; Zollinger R; Mann H; Sieberth HG
    Clin Pharmacokinet; 1993 Aug; 25(2):145-53. PubMed ID: 8403738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and dose response after intravenous and subcutaneous administration of recombinant erythropoietin in patients on regular haemodialysis treatment or continuous ambulatory peritoneal dialysis.
    Stockenhuber F; Loibl U; Gottsauner-Wolf M; Jahn C; Manker W; Meisl TF; Balcke P
    Nephron; 1991; 59(3):399-402. PubMed ID: 1758528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of epoetin in haemodialysis patients after subcutaneous administration: influence of chronic treatment.
    Schouten JP; Voorhorst G; Helbing AR; Janssen JW; Diderich PP; Op de Hoek CT
    Pharm World Sci; 1993 Dec; 15(6):252-6. PubMed ID: 8298584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.
    Salmonson T; Danielson BG; Wikström B
    Br J Clin Pharmacol; 1990 Jun; 29(6):709-13. PubMed ID: 2378790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacokinetics of recombinant human erythropoietin].
    Siniukhin VN; Stetsiuk EA; Lovchinskiĭ EV; Lebedev SV; Iarmolinskiĭ IS; Liakhov VV
    Ter Arkh; 1994; 66(8):60-2. PubMed ID: 7985158
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced production, absorption, and elimination of erythropoietin in uremia compared with healthy volunteers.
    Jensen JD; Madsen JK; Jensen LW; Pedersen EB
    J Am Soc Nephrol; 1994 Aug; 5(2):177-85. PubMed ID: 7993997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure.
    Braun A; Ding R; Seidel C; Fies T; Kurtz A; Schärer K
    Pediatr Nephrol; 1993 Feb; 7(1):61-4. PubMed ID: 8439481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
    Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in intravenous and subcutaneous application of recombinant human erythropoietin: a multicenter trial.
    Schaller R; Sperschneider H; Thieler H; Dutz W; Hans S; Voigt D; Marx M; Engelmann J; Schöter KH; Scigalla P
    Artif Organs; 1994 Aug; 18(8):552-8. PubMed ID: 7993190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics and the time course of pharmacodynamics of recombinant human erythropoietin (SNB-5001)].
    Masunaga H; Takahira R; Murase Y; Tsuda E; Sawai T
    Nihon Yakurigaku Zasshi; 1991 Aug; 98(2):143-50. PubMed ID: 1916542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vital indication for erythropoietin in a chronic haemodialysis patient. A case report.
    Nielsen OJ; Thaysen JH
    Dan Med Bull; 1989 Dec; 36(6):590-2. PubMed ID: 2612227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous recombinant human erythropoietin in patients with chronic renal failure.
    Salmonson T; Danielson BG; Grahnén A; Wikström B
    J Intern Med; 1990 Jul; 228(1):53-7. PubMed ID: 2384737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers.
    McMahon FG; Vargas R; Ryan M; Jain AK; Abels RI; Perry B; Smith IL
    Blood; 1990 Nov; 76(9):1718-22. PubMed ID: 2224121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetics of recombinant human erythropoietin in patients with various degrees of renal failure.
    Kindler J; Eckardt KU; Ehmer B; Jandeleit K; Kurtz A; Schreiber A; Scigalla P; Sieberth HG
    Nephrol Dial Transplant; 1989; 4(5):345-9. PubMed ID: 2505184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic studies on recombinant human erythropoietin.
    Salmonson T
    Scand J Urol Nephrol Suppl; 1990; 129():1-66. PubMed ID: 2255869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two years experience of daily self-administered subcutaneous erythropoietin.
    Granolleras C; Branger B; Deschodt G; Shaldon S; Nonnast-Daniel B; Pollok M
    Blood Purif; 1990; 8(5):268-71. PubMed ID: 2091686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.